These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35199097)

  • 1. Peripheral neuropathy in the pre-diabetic state of the type 2 diabetes mouse model (TSOD mice) involves TRPV1 expression in dorsal root ganglions.
    Shida K; Ohsawa M; Takahashi S; Ota H; Tamura T; Kusama N; Nakasone M; Yamazaki H; Sobue K
    IBRO Neurosci Rep; 2022 Jun; 12():163-169. PubMed ID: 35199097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bone strength and metabolism in type 2 diabetic model Tsumura, Suzuki, Obese Diabetes mice.
    Tanaka H; Yamashita T; Yoneda M; Takagi S; Miura T
    Bone Rep; 2018 Dec; 9():74-83. PubMed ID: 30094297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes model TSOD mouse is exposed to oxidative stress at young age.
    Murotomi K; Umeno A; Yasunaga M; Shichiri M; Ishida N; Abe H; Yoshida Y; Nakajima Y
    J Clin Biochem Nutr; 2014 Nov; 55(3):216-20. PubMed ID: 25411529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from singlet-oxygen-mediated oxidation to free-radical-mediated oxidation in the pathogenesis of type 2 diabetes in model mouse.
    Murotomi K; Umeno A; Yasunaga M; Shichiri M; Ishida N; Abe H; Yoshida Y; Nakajima Y
    Free Radic Res; 2015 Feb; 49(2):133-8. PubMed ID: 25381799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes.
    Miura T; Suzuki W; Ishihara E; Arai I; Ishida H; Seino Y; Tanigawa K
    Eur J Endocrinol; 2001 Dec; 145(6):785-90. PubMed ID: 11720905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity.
    Takahashi A; Tabuchi M; Suzuki W; Iizuka S; Nagata M; Ikeya Y; Takeda S; Shimada T; Aburada M
    Metabolism; 2006 Dec; 55(12):1664-9. PubMed ID: 17142141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of cardiovascular function in Tsumura Suzuki obese diabetes, a new model mouse of type 2 diabetes.
    Kawada T; Miyata S; Shimada T; Sanzen Y; Ito M; Hemmi C; Iizuka S; Suzuki W; Mihara K; Aburada M; Nakazawa M
    Biol Pharm Bull; 2010; 33(6):998-1003. PubMed ID: 20522966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Nitroquinoline 1-Oxide-Induced Tongue and Esophagus Carcinogenesis in Obese and Diabetic TSOD Mice.
    Tanaka T; Kawabata K; Sugie S
    World J Oncol; 2017 Aug; 8(4):97-104. PubMed ID: 29147443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice.
    Horie M; Miura T; Hirakata S; Hosoyama A; Sugino S; Umeno A; Murotomi K; Yoshida Y; Koike T
    Exp Anim; 2017 Oct; 66(4):405-416. PubMed ID: 28701620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ashitaba (Angelica Keiskei) Exudate Prevents Increases in Plasminogen Activator Inhibitor-1 Induced by Obesity in Tsumura Suzuki Obese Diabetic Mice.
    Ohta M; Fujinami A; Oishi K; Kobayashi N; Ohnishi K; Ohkura N
    J Diet Suppl; 2019; 16(3):331-344. PubMed ID: 29708806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus.
    Shimada T; Akase T; Kosugi M; Aburada M
    Evid Based Complement Alternat Med; 2011; 2011():931073. PubMed ID: 19208721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARγ at an Early Stage of Differentiation Enhances Adipocyte Differentiation of MEFs Derived from Type II Diabetic TSOD Mice and Alters Lipid Droplet Morphology.
    Ishibashi K; Takeda Y; Nakatani E; Sugawara K; Imai R; Sekiguchi M; Takahama R; Ohkura N; Atsumi GI
    Biol Pharm Bull; 2017; 40(6):852-859. PubMed ID: 28566629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of hypothalamic nucleobindin-2 in hyperphagic feeding in Tsumura Suzuki obese diabetes mice.
    Miyata S; Yamada N; Kawada T
    Biol Pharm Bull; 2012; 35(10):1784-93. PubMed ID: 23037168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRPV1 receptor is associated with preferential stress in large dorsal root ganglion neurons in early diabetic sensory neuropathy.
    Hong S; Agresta L; Guo C; Wiley JW
    J Neurochem; 2008 May; 105(4):1212-22. PubMed ID: 18182051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice.
    Ohsawa M; Miyabe Y; Katsu H; Yamamoto S; Ono H
    Neuroscience; 2013 Sep; 247():65-74. PubMed ID: 23685168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of progressive hearing loss in a mouse model of diabetes by oral intake of eicosapentaenoic acid ethyl ester.
    Matsuura T; Sugahara K; Yamamoto Y; Tsuda J; Hashimoto M; Yamashita H
    Acta Otolaryngol; 2023 Feb; 143(2):113-120. PubMed ID: 36722024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleuropein-Rich Diet Attenuates Hyperglycemia and Impaired Glucose Tolerance in Type 2 Diabetes Model Mouse.
    Murotomi K; Umeno A; Yasunaga M; Shichiri M; Ishida N; Koike T; Matsuo T; Abe H; Yoshida Y; Nakajima Y
    J Agric Food Chem; 2015 Aug; 63(30):6715-22. PubMed ID: 26165358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of hearing function and histopathologic changes in the cochlea of the type 2 diabetes model Tsumura Suzuki obese diabetes mouse.
    Tsuda J; Sugahara K; Hori T; Kanagawa E; Takaki E; Fujimoto M; Nakai A; Yamashita H
    Acta Otolaryngol; 2016 Nov; 136(11):1097-1106. PubMed ID: 27308832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice.
    Igarashi N; Kasai K; Tada Y; Kani K; Kato M; Takano S; Goto K; Matsuura Y; Ichimura-Shimizu M; Watanabe S; Tsuneyama K; Furusawa Y; Nagai Y
    Inflamm Res; 2024 Jul; 73(7):1081-1098. PubMed ID: 38619583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofibrinolytic phenotype in Tsumura Suzuki Obese Diabetes (TSOD) mice unrelated to hyperglycemia.
    Ohkura N; Morimoto-Kamata R; Kamikubo Y; Takahashi Y; Oishi K
    Drug Discov Ther; 2023 Nov; 17(5):346-350. PubMed ID: 37839864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.